Puma Biotechnology, Inc. (PBYI)
NASDAQ: PBYI · Real-Time Price · USD
7.51
-0.03 (-0.40%)
Apr 27, 2026, 4:00 PM EDT - Market closed

Puma Biotechnology Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
382300150206196125
Market Cap Growth
181.15%100.26%-27.40%5.24%56.62%-69.56%
Enterprise Value
313.1207.1172.02183.07225.11156.14
Last Close Price
7.515.953.054.334.233.04
PE Ratio
12.319.754.929.62--4.22
Forward PE
30.0412.5511.6210.5733.92-
PS Ratio
1.671.310.650.880.860.49
PB Ratio
2.902.301.633.869.07-51.17
P/TBV Ratio
2.922.311.633.858.80-50.51
P/FCF Ratio
9.167.193.857.68-12.396.06
P/OCF Ratio
9.147.173.857.64-12.396.06
EV/Sales Ratio
1.370.910.310.780.990.62
EV/EBITDA Ratio
6.604.291.704.156.7112.40
EV/EBIT Ratio
8.395.552.335.619.49121.04
EV/FCF Ratio
7.504.961.856.81-14.227.56
Debt / Equity Ratio
0.040.040.251.365.10-46.23
Debt / EBITDA Ratio
0.590.591.742.533.419.26
Debt / FCF Ratio
0.680.681.914.15-7.225.65
Net Debt / Equity Ratio
-0.53-0.53-0.290.291.54-14.12
Net Debt / EBITDA Ratio
-1.43-1.43-0.630.350.992.74
Net Debt / FCF Ratio
-1.65-1.65-0.690.58-2.101.67
Asset Turnover
1.061.061.041.041.021.08
Inventory Turnover
8.178.178.1510.809.4712.06
Quick Ratio
1.861.861.381.451.571.05
Current Ratio
2.002.001.541.571.731.28
Return on Equity (ROE)
27.97%27.97%41.60%57.54%0.02%693.72%
Return on Assets (ROA)
15.07%15.10%17.53%13.73%0.05%0.55%
Return on Invested Capital (ROIC)
48.44%48.53%53.68%43.17%0.19%2.69%
Return on Capital Employed (ROCE)
29.57%29.57%24.94%23.68%18.14%1.04%
Earnings Yield
8.14%10.25%20.33%10.39%0.00%-23.68%
FCF Yield
10.92%13.91%25.95%13.02%-8.07%16.50%
Buyback Yield / Dilution
-3.16%-3.16%-3.26%-5.83%-10.56%-2.69%
Total Shareholder Return
-3.16%-3.16%-3.26%-5.83%-10.56%-2.69%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q